Antimalarial agent artesunate induces G0/G1 cell cycle arrest and apoptosis via increasing intracellular ROS levels in normal liver cells. (December 2020)

• Record Type: Journal Article
• Authors: Yin, S; Yang, H; Zhao, X; Wei, S; Tao, Y; Liu, M; Bo, R; Li, J
• Is Part Of: Human & experimental toxicology. Volume 39:Number 12(2020)
• Page Start: 1681
• Page End: 1689
• Publication Date: 2020-12
• Subjects: Artesunate -- BRL-3A cells -- cell cycle arrest -- apoptosis; Toxicology -- Periodicals; 615.9
• DOI: 10.1177/0960327120937331
• Languages: English
• ISSNs: 0960-3271

Abstract

Artesunate (ARS) has been shown to be highly effective against chloroquine-resistant malaria. In vitro studies reported that ARS has anticancer effects; however, its detrimental action on cancer cells may also play a role in its toxicity toward normal cells and its potential toxicity has not been sufficiently researched. In this study, we investigated the possible cytotoxic effects using normal BRL-3A and AML12 liver cells. The results showed that ARS dose-dependently inhibited cell proliferation and arrested the G0/G1 phase cell cycle in both BRL-3A and AML12 liver cells. Western blotting demonstrated that ARS induced a significant downregulation of cyclin-dependent kinase-2 (CDK2), CDK4, cyclin D1, and cyclin E1 in various levels and then caused apoptosis when the Bcl-2/Bax ratio decreased. Conversely, the levels of intracellular reactive oxygen species (ROS) were increased. The ROS scavenger N -acetylcysteine can significantly inhibit cell cycle arrest and apoptosis induced by ARS. Thus, the data confirmed that ARS exposure impairs normal liver cell proliferation by inducing G0/G1 cell cycle arrest and apoptosis, and this detrimental action may be associated with intracellular ROS accumulation. Collectively, the possible side effects of ARS on healthy normal cells cannot be neglected when developing therapies.